Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art

References

• Lieu CH, William WN, Lippman SM. Cancer chemoprevention. In: Hidalgo M, Eckhardt SG, Garrett-Mayer E, et al., editors. Principles of anticancer drug development. New York: Springer Science; 2010. p. 1–18. ​
   Google Scholar
• WHO. Cancer-fact sheets. WHO; [ cited 2017 Jan 2]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/index.html
   Google Scholar
• Sabitha M, Sanoj Rejinold NS, Nair A, et al. Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydr Polym. 2013;91:48–57.
   PubMed Web of Science ®Google Scholar
• Smith RA, Andrews K, Brooks D, et al. Cancer screening in the United States, 2016: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2016;62:95–102.
   Google Scholar
• Cevc G. Material transport across permeability barriers by means of lipid vesicles. In: Lipowsky R, editor. Handbook of physics of biological systems. Vol. I. Vol. 9. Amsterdam: Elsevier Science; 1994. p. 441–466.
   Google Scholar
• Cevc G, Blume G, Schatzlein A, et al. The skin: a pathway for the systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev. 1996;18:349–378.
   Web of Science ®Google Scholar
• Cevc G, Schatzleinand A, Blume G. Transdermal drug carriers: basic properties, optimization and transfer-efficiency in the case of epicutaneously applied peptides. J Control Release. 1995;36:3–16.
   Web of Science ®Google Scholar
• Mezei M, Gulasekharn V. Liposomes a selective drug delivery system for topical route of administration, 1. Lotion dosages form. Life Sci. 1980;26:1473–1477.
   PubMed Web of Science ®Google Scholar
• Fresta M, Puglisi G. Application of liposomes as potential cutaneous drug delivery system: in vitro in vivo investigation with radioactivity labeled vesicles. J Drug Target. 1996;4:95–101.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Lipid vesicles penetrate into skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104:226–232.
   PubMed Web of Science ®Google Scholar
• Song CK, Balakrishnan P, Shim CK, et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2012;92:299–304.
   PubMed Web of Science ®Google Scholar
• Shashank J, Niketkumar P, Mansi KS, et al. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. J Pharm Sci. 2016;116:1–23.
   Google Scholar
• Cevc G, Blume G. New highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochimica Et Biophysica Acta. 2001;1514(2):191–205.
   PubMed Web of Science ®Google Scholar
• Biju SS, Talegaonkar S, Mishra PR, et al. Vesicular system an overview. ‎Indian J Pharm Sci. 2006;68:141–153.
   Google Scholar
• Dayan N, Touitou E. Carriers for skin delivery of Trihexiphenidyl HCl ethosomes vs liposomes. Biomaterials. 2000;21:1879–1885.
   PubMed Web of Science ®Google Scholar
• Hofer C, Hartung R, Gobel R, et al. New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-alpha theoretic and practical aspects. World J Surg. 2000;24:1187–1189.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Jantrawuta P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm. 2008;360:156–163.
   PubMed Web of Science ®Google Scholar
• Zheng W, Fang Xia Wang L, Zhang Y. Preparation and quality assessment of itraconazole transfersomes. Int J Pharm. 2012;436:291–298.
   PubMed Web of Science ®Google Scholar
• Cevc G, Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersome. Biochim Biophys Acta. 2003;1614:156–164.
   PubMed Web of Science ®Google Scholar
• Ahad A, Aqil M, Kohli K, et al. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomed Nanotechnol Biol Med. 2012;8:237–249.
   PubMed Web of Science ®Google Scholar
• Jain S, Mishra D, Kuksal A, et al. Vesicular approach for drug delivery into or across the skin: current status and future prospects. Pharm Online. 2006;1:1–32.
   Google Scholar
• Morrow DIJ, McCarron PA, Woolfson AD, et al. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Deliv J. 2007;1:36–59.
   Google Scholar
• Zaafarany GME, Awad GAS, Holayel SM, et al. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397:164–172.
   Google Scholar
• Jain S, Jain P. Transferosomes: a novel vesicular carrier for enhanced transdermal delivery: development, characterization and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013–1026.
   PubMed Web of Science ®Google Scholar
• Bhardwaj V, Shukla V, Singh A, et al. Transferosomes ultra flexible vesicles for transdermal delivery. Int J Pharm Sci Res. 2010;2:12–20.
   Google Scholar
• Schatzlein A, Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high resolution confocal laser scanning microscopy study using highly deformable vesicles (transfersomes). Brit J Dermatol. 1998;138:583–592.
   PubMed Web of Science ®Google Scholar
• Planas ME, Gonzalez P, Rodriguez L, et al. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth Analg. 1992;75:615–621.
   PubMed Web of Science ®Google Scholar
• Mahor S, Rawat A, Dubey PK, et al. Cationic transfersomes based topical genetic vaccine against hepatitis B. Int J Pharm. 2007;340:13–19.
   PubMed Web of Science ®Google Scholar
• Choi MJ, Maibach HI. Elastic vesicles as topical/transdermal drug delivery system. Int J Cosm Sci. 2005;27:211–221.
   PubMedGoogle Scholar
• Guo J, Ping Q, Sun G, et al. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm. 2000;194:201–207.
   PubMed Web of Science ®Google Scholar
• Paul A, Cevc G, Bachhawat BK. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine. 1998;16:188–195.
   PubMed Web of Science ®Google Scholar
• Gmm EM, Williams AC, Barry BW. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharma Pharmacol. 2001;53:1069–1077.
   Google Scholar
• Costa CAM, Moraes AM. Encapsulation of 5-fluorouracil in liposomes for topical administration. Acta Sci Tech. 2003;25:53–61.
   Google Scholar
• Alvi IA, Madan J, Kaushik D, et al. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs. 2011;8:774–782.
   Web of Science ®Google Scholar
• Ita KB, Du Preez J, Lane ME, et al. Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants. J Pharma Pharmacol. 2007;59:1215–1222.
   Web of Science ®Google Scholar
• El Zaafarany GM, Awad GAS, Holayel SM, et al. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm. 2010;397:164–172.
   PubMed Web of Science ®Google Scholar
• Badran M, Shalaby K, Al-Omrani A. Influence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: dependency on their composition. Sci World J. 2012;2012:1–9.
   Web of Science ®Google Scholar
• Cevc G, Blume G, Schatzlein A. Transferosomes-mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J Control Release. 1997;45:211–226.
   Web of Science ®Google Scholar
• Chen J, Lu WL, Gu W, et al. Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv. 2013;10:845–856.
   PubMed Web of Science ®Google Scholar
• Dragicevic-Curic N, Gräfe S, Gitter B, et al. Surface charged temoporfin-loaded flexible vesicles: in vitro skin penetration studies and stability. Int J Pharm. 2010;384:100–108.
   PubMed Web of Science ®Google Scholar
• Dubey V, Mishra D, Asthana A, et al. Transdermal delivery of a pineal hormone: melatonin via elastic liposomes. Biomaterials. 2006;27:3491–3496.
   PubMed Web of Science ®Google Scholar
• Myschik J, Rades T, Hook S. Advances in lipid based subunit vaccine formulations. Curr Immunol Rev. 2009;5:42–48.
   Google Scholar
• Kumar R, Philip A. Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Tropic J Pharm Res. 2007;6:633–644.
   Web of Science ®Google Scholar
• Owens DR. New horizons – alternative routes for insulin therapy. Nat Rev. 2002;1:529–540.
   Google Scholar
• Cevc G, Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release. 2010;141:277–299.
   PubMed Web of Science ®Google Scholar
• Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin Pharmacokinet. 2003;42:461–474.
   PubMed Web of Science ®Google Scholar
• Kumar R, Philip A. Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Tropic J Pharm Res. 2007;6:633–644.
   Web of Science ®Google Scholar
• Maurya SD. Enhanced transdermal delivery of Indinavir sulphate via transfersomes. Int J Comp Pharm. 2010;1:1–7.
   Google Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13:238–252.
   PubMed Web of Science ®Google Scholar
• Singh H, Utreja P, Tiwary A, et al. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity. Aaps J. 2009;11:54–64.
   PubMed Web of Science ®Google Scholar
• Abdallah M. Transferosomes as a transdermal drug delivery system for enhancement the antifungal activity of nyastatin. Int J Pharm Pharm Sci. 2013;5:560–567.
   Google Scholar
• Sazoka F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci. 1978;75:4194–4198.
   Web of Science ®Google Scholar
• Rai K. Transfersomes: self-optimizing carriers for bioactives. PDA J Pharm Sci Technol. 2008;62:362–379.
   PubMedGoogle Scholar
• Kumar A, Adde S, Kamble R, et al. Development and characterization of liposomal drug delivery system for nimesulide. Int J Pharm Pharm Sci. 2010;2:87–89.
   Google Scholar
• Charcosset C, Juban A, Valour J, et al. Preperation of liposomes at large scale using ethanol injection method: effect of scale up and injection devices. Chem Eng Res Des. 2015;94:508–515.
   Web of Science ®Google Scholar
• Maestrelli F, Rodriguez M, Rabasco A, et al. Effect of preparation techniques on the properties of liposomes encapsulating ketoprofen- cyclodextrine complexes aimed for transdermal delivery. Int J Pharm. 2006;312:53–60.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ng W, Feng X, et al. Lipid vesicular nanocarrier: quick encapsulation efficiency determination and transcutaneous application. Int J Pharm. 2017 10;516:225–230.
   PubMed Web of Science ®Google Scholar
• Schlich M, Lai F, Murgia S, et al. Needle-free jet injection of intact phospholipid vesicles across the skin: a feasibility study. Biomed Microdevices. 2016;18:67.
   Web of Science ®Google Scholar
• Meng S, Zhang C, Shi W, et al. Preparation of osthole-loaded nano-vesicles for skin delivery: characterization, in vitro skin permeation and preliminary in vivo pharmacokinetic studies. Eur J Pharm Sci. 2016;92:49–54.
   PubMed Web of Science ®Google Scholar
• Hassanpour AM, Ghanbarzadeh S, Javadzadeh Y, et al. Aggregated nanotransfersomal dry powder inhalation of itraconazole for pulmonary drug delivery. Adv Pharm Bull. 2016;6:57–64.
   Web of Science ®Google Scholar
• González-Rodríguez ML, Arroyo CM, Cózar-Bernal MJ, et al. Deformability properties of timolol-loaded transfersomes based on the extrusion mechanism, statistical optimization of the process. Drug Dev Ind Pharm. 2016;42:1683–1694.
   PubMed Web of Science ®Google Scholar
• Garg V, Singh H, Bhatia A, et al. Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment. AAPS Pharmscitech. 2017;18:58–71.
   PubMed Web of Science ®Google Scholar
• Shreya AB, Managuli RS, Menon J, et al. Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations. J Liposome Res. 2016;26:221–232.
   PubMed Web of Science ®Google Scholar
• Seidel EJ, Rother M, Regenspurger K, et al. A randomised trial comparing the efficacy and safety of topical ketoprofen in Transfersome(®) gel (IDEA-033) with oral ketoprofen and drug-free ultra-deformable Sequessome™ vesicles (TDT 064) for the treatment of muscle soreness following exercise. J Sports Sci. 2016;34:88–95.
   PubMed Web of Science ®Google Scholar
• Lu K, Xie S, Han S, et al. Preparation of a nano emodin transfersome and study on its anti-obesity mechanism in adipose tissue of diet-induced obese rats. J Transl Med. 2014;12:72.
   PubMed Web of Science ®Google Scholar
• Sarwa KK, Mazumder B, Rudrapal M, et al. Potential of capsaicin-loaded transfersomes in arthritic rats. Drug Deliv. 2015;22:638–646.
   PubMed Web of Science ®Google Scholar
• Ghanbarzadeh S, Arami S. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. Biomed Res Int. 2013;2013:1–7.
   Web of Science ®Google Scholar
• Ghannoum M, Isham N, Henry W, et al. Evaluation of the morphological effects of TDT 067 (terbinafine in Transfersome) and conventional terbinafine on dermatophyte hyphae in vitro and in vivo. Antimicrob Agents Chemother. 2012;56:2530–2534.
   PubMed Web of Science ®Google Scholar
• Zhang YT, Xu YM, Zhang SJ, et al. In vivo microdialysis for the evaluation of transfersomes as a novel transdermal delivery vehicle for cinnamic acid. Drug. 2014;40:301–307.
   Google Scholar
• Sigurgeirsson B, Ghannoum M. Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis. Expert Opin Investig Drugs. 2012;21:1549–1562.
   PubMed Web of Science ®Google Scholar
• Rajan R, Vasudevan DT. Effect of permeation enhancers on the penetration mechanism of transfersomal gel of ketoconazole. J Adv Pharm Technol Res. 2012;3:112–116.
   PubMedGoogle Scholar
• Kaur CD, Saraf S. Topical vesicular formulations of Curcuma longa extract on recuperating the ultraviolet radiation-damaged skin. J Cosmet Dermatol. 2011;10:260–265.
   PubMed Web of Science ®Google Scholar
• Duangjit S, Opanasopit P, Rojanarata T, et al. Characterization and in vitro skin permeation of meloxicam-loaded liposomes versus transfersomes. J Drug Deliv. 2011;2011:418316.
   PubMedGoogle Scholar
• Rother M, Seidel EJ, Clarkson PM, et al. Efficacy of epicutaneous Diractin (ketoprofen in Transfersome gel) for the treatment of pain related to eccentric muscle contractions. Drug Des Devel Ther. 2009;3:143–149.
   PubMed Web of Science ®Google Scholar
• Cevc G, Mazgareanu S, Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int J Pharm. 2008;360:29–39.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Hou SX, Chen T, et al. Preparation and characterization of transfersomes of three drugs in vitro. Zhongguo Zhong Yao Za Zhi. 2006;31:728–731.
   Google Scholar
• Li S, Qiu Y, Zhang S, et al. Enhanced transdermal delivery of 18β-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2012;38:855–865.
   PubMed Web of Science ®Google Scholar
• Chen G, Li D, Jin Y, et al. Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catechin. Drug Dev Ind Pharm. 2014;40:260–265.
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Debernardi F, et al. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm. 2002;241:319–327.
   PubMed Web of Science ®Google Scholar
• Elsayed MM, Abdallah OY, Naggar VF, et al. Deformable liposomes and ethosomes: mechanism of enhanced skin delivery. Int J Pharm. 2006;322:60–66.
   PubMed Web of Science ®Google Scholar
• Cadena PG, Pereira MA, Cordeiro RBS, et al. Nanoencapsulation of quercetin and resveratrol into elastic liposomes. Biochim Biophys Acta. 2013;1828:309–316.
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mishra V, Rawat A, et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm. 2005;293:73–82.
   PubMed Web of Science ®Google Scholar
• Vanic Z, Hafner A, Bego M, et al. Characterization of various deformable liposomes with metronidazole. Drug Dev Ind Pharm. 2013;39:481–488.
   PubMed Web of Science ®Google Scholar
• Schmitt JV, Miot HA. Actinic keratosis: a clinical and epidemiological revision. An Bras Dermatol. 2012;87:425–434.
   PubMed Web of Science ®Google Scholar
• Memon AA, Tomenson JA, Bothwell J, et al. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol. 2000;142:1154–1159.
   PubMed Web of Science ®Google Scholar
• Gupta AK, Paquet M, Villanueva E, et al. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12:CD004415.
   PubMed Web of Science ®Google Scholar
• Alvi IA, Madan J, Kaushik D, et al. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs. 2011;22:774–782.
   PubMed Web of Science ®Google Scholar
• Khan MA, Pandit J, Sultana Y, et al. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv. 2015;22:795–802.
   PubMed Web of Science ®Google Scholar
• Holmes SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-1998. Br J Dermatol. 2000;143:1224–1229.
   PubMed Web of Science ®Google Scholar
• Marks R, Staples M, Giles G. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer. 1993;53:585–590.
   PubMed Web of Science ®Google Scholar
• Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30:774–778.
   PubMed Web of Science ®Google Scholar
• Lear JT, Tan BB, Smith AP, et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med. 1997;90:371–374.
   PubMed Web of Science ®Google Scholar
• Corona R, Dogliotti E, Errico M, et al. Risk factors for basal cell carcinoma in a Mediterranean population. Arch Dermatol. 2002;137:1162–1168.
   Google Scholar
• Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. Arch Dermatol. 1995;131:157–163.
   PubMed Web of Science ®Google Scholar
• Yamada M, Kodama K, Fujita S, et al. Prevalence of skin neoplasms among the atomic bomb survivors. Radiat Res. 1996;146:223–226.
   PubMed Web of Science ®Google Scholar
• Maloney ME. Arsenic in dermatology. Dermatol Surg. 1996;22:301–304.
   PubMed Web of Science ®Google Scholar
• Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49:506–509.
   PubMed Web of Science ®Google Scholar
• Fadel M, Samy N, Nasr M, et al. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharm Dev Technol. 2017;22(4): 545–550. ​
   Web of Science ®Google Scholar
• Friedman-Kien AE, Saltzman BR, Cao YZ, et al. Kaposi’s sarcoma in HIV-negative homosexual men. Lancet. 1990;335(8682):168–169.
   PubMed Web of Science ®Google Scholar
• Penn I. Kaposi’s sarcoma in organ transplant recipients: report of 20 cases. Transplantation. 1979;27:8–11.
   PubMed Web of Science ®Google Scholar
• Pathak K, Sharma V, Sharma M. Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma. Artif Cells Nanomed Biotechnol. 2016;44:1671–1683.
   PubMed Web of Science ®Google Scholar
• Urba WJ, Washington CV, Nadiminti H. Cancer of the skin. In: Longo DL, Fauci AS, Kasper DL, editors. Harrison’s principles of internal medicine. 18th ed. New York, NY: McGraw-Hill Medical; 2012.
   Google Scholar
• American Cancer Society. What are the key statistics about melanoma? [ cited 2017 Jan 01]. Available from: www.cancer.org/Cancer/SkinCancer-Melanoma/Detailed-Guide/melanoma-skin-cancer-key-statistics
   Google Scholar
• O’Bryant CL, Poust JC. Melanoma. In: DiPiro JT, Talbert RL, Yee GC, editors. Pharmacotherapy: a pathophysiologic approach. 8th ed. New York: McGraw-Hill Medical; 2011.
   Google Scholar
• Lin M-W, Huang Y-B, Chen C-L, et al. A formulation study of 5-aminolevulinic encapsulated in DPPC liposomes in melanoma treatment. Int J of Med Sci. 2016;13:483–489.
   Web of Science ®Google Scholar
• Dorrani M, Olga BG, Tamara M, et al. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. J Control Release. 2016;228:150–158.
   PubMed Web of Science ®Google Scholar
• Marinkovich MP. Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer. 2007;7:370–380.
   PubMed Web of Science ®Google Scholar
• Lee DA, Miller SJ. Nonmelanoma skin cancer. Facial Plast Surg Clin North Am. 2009;17:309–324.
   Google Scholar
• Akgul B, Cooke JC, Storey A. HPV-associated skin disease. J Pathol. 2006;208:165–175.
   PubMed Web of Science ®Google Scholar
• Moloney FJ, Comber H, O’Lorcain P, et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol. 2006;154:498–504.
   PubMed Web of Science ®Google Scholar
• Morita A. Tobacco smoke causes premature skin aging. J Dermatol Sci. 2007;48:169–175.
   PubMed Web of Science ®Google Scholar
• Gupta V, Karthikeyan C, Trivedi P. Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransfersome formulation. Arch Pharm Res. 2012;35:51–859.
   Web of Science ®Google Scholar
• Ming K, Lin H, Juan W, et al. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy. J Royal Soc Chem. 2014;51(8):1453–1456.. ​
   Google Scholar
• Paolino D, Licciardi M, Celia C, et al. Folate- targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model. Euro J Pharm and Biopharm. 2012;82:94–102.
   Web of Science ®Google Scholar
• Alvi IA, Madan J, Kaushik D, et al. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drug. 2011;22:774–782.
   Google Scholar
• Mahmood S, Taher M, Mandal UK. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application. Int J Nanomedicine. 2014 12;9:4331–4346.
   PubMed Web of Science ®Google Scholar
• Bragagni M, Mennini N, Maestrelli F, et al. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib. Drug Deliv. 2012;19:354–361.
   PubMed Web of Science ®Google Scholar
• Maswadeh H, Demetzos C, Dimas K, et al. Accumulation of vinblastine into transfersomes and liposomes in response to a transmembrane ammonium sulfate gradient and their cytotoxic/cytostatic activity in vitro. Anticancer Res. 2001;21:2577–2583.
   PubMed Web of Science ®Google Scholar
• Cevc G. Preparation for the application of agents in mini-droplets. United States patent US 6165500 A. 2000.
   Google Scholar
• Cevc G. Preparation for the transport of an active substance across barriers. United States patent US 20020048596 A1. 2002.
   Google Scholar
• Perricone N. Topical drug delivery using phosphatidylcholine. United States patent US 20060105955 A1. 2006.
   Google Scholar
• Cevc G. Formulation for topical non-invasive application in vivo. United States patent US 7175850 B2. 2007.
   Google Scholar
• Cevc G. Preparation for the application of agents in mini-droplets. United States patent US 20070042030 A1. 2007.
   Google Scholar
• Cevc G, Richardsen H, Weiland-Waibe A Method for the improvement of transport across adaptable semi-permeable barriers. United States patent US 7591949 B2. 2009.
   Google Scholar
• William H, Henk-Andre K, Linda S. Methods of reducing the proliferation and viability of microbial agents. PCT WO2010/090654 A1. 2010.
   Google Scholar
• Cevc G, Chopra A. Non-invasive vaccination through the skin. United States patent US 7867480 B1. 2011.
   Google Scholar
• Richard WG, William H. Vesicles .PCT/European Patent. CA 2919971 A1. 2015.
   Google Scholar
• Modi P. Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation. United States patent US 20150157728 A1. 2015.
   Google Scholar